dual OX-R1/CRF-R1 antagonists (Hager Biosciences)

N/A

Report date: 2025/03/19 11:38:59
NME

Base Information

Drug Namedual OX-R1/CRF-R1 antagonists (Hager Biosciences)
Drug Alias Namedual orexin-1 and corticotropin-releasing factor receptor-1 antagonists (Hager Biosciences)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrexin receptor type 1 antagonistsCorticotropin-releasing factor receptor 1 antagonists
TargetsCorticotropin-releasing factor receptor 1Orexin receptor type 1
Therapy Area/IndicationsTobacco Use Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHager Biosciences LLC
China Registration ClassN/A

Develop Information

Active CompaniesHager Biosciences LLC
Inactive CompaniesN/A
Active IndicationsTobacco Use Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A